SCHEMBL30851652

SCHEMBL30851652

CON(C)C(=O)c1ccc(C)nc1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 6/20 0.37
MTOR P42345 6/20 0.37
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
CLK1 P49759 1/20 0.35
DYRK1A Q13627 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
TRPM8 Q7Z2W7 2/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NNMT P40261 1/20 0.35
IKBKB O14920 1/20 0.35
LIMK1 P53667 1/20 0.35
MLYCD O95822 1/20 0.35
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16460198 0.83 NNMT (0.40) PIK3CAMTORALDH1A1KDM4EHPGD
SCHEMBL3834955 0.83 TUBB4A (0.41) PIK3CAMTORALDH1A1KDM4EHPGD
SCHEMBL847606 0.81 EGFR (0.43) PIK3CAMTORALDH1A1CLK1DYRK1A
SCHEMBL20116582 0.81 MLYCD (0.38) PIK3CAMTORKDM4ECLK1DYRK1A
SCHEMBL1266209 0.76 KDM4E (0.54) ALDH1A1KDM4EHPGDMAPTGLA
SCHEMBL29942878 0.76 KDM4E (0.54) ALDH1A1KDM4EHPGDMAPTGLA
SCHEMBL14917429 0.73 PARP1 (0.53) ALDH1A1KDM4EHPGDMAPTNNMT
SCHEMBL18840131 0.73 SMN1; SMN2 (0.43) ALDH1A1KDM4EHPGDIKBKBLIMK1
SCHEMBL167457 0.73 GABRP (0.55) ALDH1A1KDM4EMAPTGABRPGABRD
SCHEMBL11969585 0.73 GRM5 (0.36) PIK3CAMTORALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587014-A2 C5AR1 ANTAGONISTS AND USES THEREOF Vanqua Bio, Inc. (US) 2025-07-23 EP disclosed
WO-2024059096-A2 C5AR1 ANTAGONISTS AND USES THEREOF VANQUA BIO, INC. (US) 2024-03-21 WO disclosed